INO $2.13 +253.6%CLRO $5.38 +57.8%SLGB $0.4126 +35.2%NFE $5.60 +13.8%
Afterhours scan · 6:30 PM ET

Real companies. Real catalysts. Ahead of the crowd.

Small-cap catalysts
before the crowd
catches up.

Daily market movers, filings, financings, clinical updates, contracts, and CEO conversations.

Small companies. Bigger perspective.

Latest news.

View all news
Live staging archive · Imported WordPress contentGet the brief

Market movers.

Latest scanner results
Gainers
Latest small-cap mover scan results.
TickerPriceChangeVolumeCatalystDetails
INO$2.13+253.6%50.0MINOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP)
CLRO$5.38+57.8%1.9MVivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
SLGB$0.4126+35.2%24.9MBC-Most Active Stocks
NFE$5.60+13.8%525.8KNew Fortress Energy Inc. Successfully Completes Restructuring and Recapitalization Transaction & Capital Raise Participation
ABOS$0.2350+11.9%7.5MAcumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint
VCIG$0.1872+10.8%19.8MVCI Global Advances AI Infrastructure and Token Services Strategy; Strengthens Balance Sheet in 1H2026
CAPR$7.02+10.0%522.9KCAPR Stock on Track For Worst Month Since July AdCom Vote On Deramiocel As November FDA Decision Nears
TSHA$4.48+8.5%337.0KDoes Early Rett Trial Success Change The Bull Case For Taysha Gene Therapies (TSHA)?
Click a ticker for its company snapshot.8 tickers · Afterhours scan

CEO conversations.

Meet the story

For public companies / issuers

Reach investors following
the small-cap market.

Tell your story through sponsored features, executive interviews, and targeted distribution.

Paid partnerships are clearly labeled and separate from editorial coverage.